검색

상세정보

  • HOME
  • 상세정보


Current Medical Diagnosis & Treatment 2021 [electronic resource]

Papadakis, Maxine A.

책이미지
Current Medical Diagnosis & Treatment 2021  [electronic resource] 표지이미지
도서 상세정보
서평쓰기
서평쓰기
책이미지

QRcode

QR Code
QRcode 사용방법
QRcode 사용방법
QR코드 정의
사각형의 가로세로 격자무늬에 다양한 정보를 담고 있는 2차원(매트릭스)형식의 코드로 스마트폰으로 QR코드를 스캔하면 각종 정보를 제공 받을 수 있습니다.
QR코드 인식프로그램
스마트폰 마켓에 들어가면 'QR코드 스캔 프로그램'을 검색해 무료 어플을 다운받아 사용하시면 됩니다.
도서정보 QR코드 이용하기
도서 상세정보에서 QR코드를 스캔하면, 모바일 웹페이지로 연결되어 해당 도서의 상세정보 및 소장정보 등을 확인 할 수 있습니다.
상세정보
자료유형단행본
개인저자Papadakis Maxine A..ed.
McPhee Stephen J.ed.
Rabow Michael W.ed.
서명/저자사항Current Medical Diagnosis & Treatment 2021[electronic resource] /Maxine A. Papadakis, Stephen J. McPhee, Michael W. Rabow.
발행사항New York, N.Y. :AccessMedicine,c2021.
형태사항1 online resource :ill., figs., tables.
총서사항McGraw-Hill's AccessMedicine
A Lange medical book
총서부출표목McGraw-Hill's AccessMedicine.A Lange medical book.
기타형태 저록Online version:Current Medical Diagnosis & Treatment 2021.New York, N.Y. : McGraw-Hill Education LLC.,2021.
ISBN9781260469868 (print-ISBN)
1260469867 (print-ISBN)
일반주기 "A Lange medical book."
서지주기Includes bibliographical references and indexes.
내용주기Year in Review -- Anti-Infective Chemotherapeutic & Antibiotic Agents -- Bacterial & Chlamydial Infections -- Blood Disorders -- Blood Vessel & Lymphatic Disorders -- Breast Disorders -- Cancer -- Common Problems in Infectious Diseases & Antimicrobial Therapy -- Common Symptoms -- Dermatologic Disorders -- Diabetes Mellitus & Hypoglycemia -- Disease Prevention & Health Promotion -- Disorders of Hemostasis, Thrombosis, and Antithrombotic Therapy -- Endocrine Disorders -- Gastrointestinal Disorders -- Genetic & Genomic Disorders -- Geriatric Disorders -- Heart Disease -- HIV Infection & AIDS -- Integrative Medicine -- Kidney Disease -- Lipid Disorders -- Liver, Biliary Tract, & Pancreas Disorders -- Mycotic Infections -- Nervous System Disorders -- Palliative Care & Pain Management -- Poisoning -- Preoperative Evaluation & Perioperative Management -- Protozoal & Helminthic Infections -- Psychiatric Disorders -- Pulmonary Disorders -- Rheumatologic, Immunologic, & Allergic Disorders -- Sexual & Gender Minority Health -- Sports Medicine & Outpatient Orthopedics -- Systemic Hypertension -- Urologic Disorders -- Viral & Rickettsial Infections -- Women's Health Issues -- Part 1: Disease Prevention & Health Promotion -- 1-01: General Approach to the Patient -- 1-02: Health Maintenance & Disease Prevention -- 1-03: Prevention of Infectious Diseases -- 1-04: Prevention of Cardiovascular Disease -- 1-05: Prevention of Osteoporosis -- 1-06: Prevention of Physical Inactivity -- 1-07: Prevention of Overweight & Obesity -- 1-08: Cancer Prevention -- 1-09: Prevention of Injuries & Violence -- 1-10: Prevention of Substance Use Disorder: Alcohol & Illicit Drugs -- Part 2: Common Symptoms -- 2-01: Overview: Common Symptoms -- 2-02: Cough -- 2-03: Dyspnea -- 2-04: Hemoptysis -- 2-05: Chest Pain -- 2-06: Palpitations -- 2-07: Lower Extremity Edema -- 2-08: Fever & Hyperthermia -- 2-09: Involuntary Weight Loss -- 2-10: Fatigue & Chronic Fatigue Syndrome -- 2-11: Acute Headache -- 2-12: Dysuria -- Part 3: Preoperative Evaluation & Perioperative Management -- 3-01: Overview: Preoperative Evaluation & Perioperative Management -- 3-02: Physiologic Effects of Anesthesia & Surgery -- 3-03: Preoperative Evaluation of the Asymptomatic Patient -- 3-04: Cardiac Risk Assessment & Reduction in Noncardiac Surgery -- 3-05: Pulmonary Evaluation in Non-Lung Resection Surgery -- 3-06: Preoperative Evaluation of the Patient with Liver Disease -- 3-07: Preoperative Hematologic Evaluation -- 3-08: Preoperative Neurologic Evaluation -- 3-09: Perioperative Management of Endocrine Diseases -- 3-10: Perioperative Management of Kidney Disease -- 3-11: Antibiotic Prophylaxis of Surgical Site Infections -- Part 4: Geriatric Disorders -- 4-01: Overview: Geriatric Disorders -- 4-02: General Principles of Geriatric Care -- 4-03: Comprehensive Assessment of the Older Adult -- 4-04: Management of Common Geriatric Problems -- Part 5: Palliative Care & Pain Management -- 5-01: Definition & Scope of Palliative Care -- 5-02: Palliation of Common Nonpain Symptoms -- 5-03: Care of Patients at the End of Life -- 5-04: Tasks After Death -- 5-05: Taxonomy of Pain -- 5-06: Acute Pain -- 5-07: Chronic Noncancer Pain -- 5-08: Cancer Pain -- 5-09: Pain at the End of Life -- 5-10: Principles of Pain Management -- 5-11: Pharmacologic Pain Management Strategies -- 5-12: Integrative Therapies & Other Pain Management -- 5-13: Selected Interventional Modalities for Pain Relief -- Part 6: Dermatologic Disorders -- 6-01: Overview: Dermatologic Disorders -- 6-02: Principles of Dermatologic Therapy -- 6-03: Melanocytic Nevi (Normal Moles) -- 6-04: Atypical Nevi -- 6-05: Blue Nevi -- 6-06: Freckles & Lentigines -- 6-07: Seborrheic Keratoses -- 6-08: Malignant Melanoma -- 6-09: Atopic Dermatitis -- 6-10: Lichen Simplex Chronicus (Circumscribed Neurodermatitis) -- 6-11: Psoriasis -- 6-12: Pityriasis Rosea -- 6-13: Seborrheic Dermatitis -- 6-14: Fungal Infections of the Skin -- 6-15: Cutaneous Lupus Erythematosus -- 6-16: Cutaneous T-Cell Lymphoma (Mycosis Fungoides) -- 6-17: Exfoliative Dermatitis (Exfoliative Erythroderma) -- 6-18: Miscellaneous Scaling Dermatoses -- 6-19: Intertrigo -- 6-20: Herpes Simplex (Cold or Fever Sore; Genital Herpes) -- 6-21: Variola (Smallpox) & Vaccinia -- 6-22: Pompholyx -- 6-23: Porphyria Cutanea Tarda -- 6-24: Dermatitis Herpetiformis -- 6-25: Impetigo -- 6-26: Contact Dermatitis -- 6-27: Acne Vulgaris -- 6-28: Rosacea -- 6-29: Folliculitis (Including Sycosis) -- 6-30: Miliaria (Heat Rash) -- 6-31: Mucocutaneous Candidiasis -- 6-32: Reactive Erythemas -- 6-33: Infectious Erythemas -- 6-34: Pemphigus -- 6-35: Bullous Pemphigoid -- 6-36: Warts -- 6-37: Callosities & Corns of Feet or Toes -- 6-38: Molluscum Contagiosum -- 6-39: Basal Cell Carcinoma -- 6-40: Squamous Cell Carcinoma -- 6-41: Lichen Planus -- 6-42: Kaposi Sarcoma -- 6-43: Pruritus -- 6-44: Anogenital Pruritus -- 6-45: Scabies -- 6-46: Pediculosis -- 6-47: Skin Lesions Due to Other Arthropods -- 6-48: Erythema Nodosum -- 6-49: Furunculosis (Boils) & Carbuncles -- 6-50: Epidermal Inclusion Cyst -- 6-51: Photodermatitis -- 6-52: Leg Ulcers Secondary to Venous Insufficiency -- 6-53: Pigmentary Disorders -- 6-54: Alopecia -- 6-55: Nail Disorders -- 6-56: Drug Eruption (Dermatitis Medicamentosa) -- Part 7: Disorders of the Eyes & Lids -- 7-01: Symptoms of Ocular Disease -- 7-02: Ocular Examination -- 7-03: Ophthalmologic Referrals -- 7-04: Refractive Errors -- 7-05: Disorders of the Lids & Lacrimal Apparatus -- 7-06: Conjunctivitis -- 7-07: Pinguecula & Pterygium -- 7-08: Corneal Ulcer -- 7-09: Infectious Keratitis -- 7-10: Acute Angle-Closure Glaucoma -- 7-11: Chronic Glaucoma -- 7-12: Uveitis -- 7-13: Cataract -- 7-14: Retinal Detachment -- 7-15: Vitreous Hemorrhage -- 7-16: Age-Related Macular Degeneration -- 7-17: Central & Branch Retinal Vein Occlusions -- 7-18: Central & Branch Retinal Artery Occlusions -- 7-19: Transient Monocular Visual Loss -- 7-20: Retinal Disorders Associated with Systemic Diseases -- 7-21: Ischemic Optic Neuropathy -- 7-22: Optic Neuritis -- 7-23: Optic Disk Swelling -- 7-24: Cranial Nerve Palsies -- 7-25: Thyroid Eye Disease (Graves Ophthalmopathy) -- 7-26: Orbital Cellulitis -- 7-27: Ocular Trauma -- 7-28: Ultraviolet Keratitis (Actinic Keratitis) -- 7-29: Chemical Conjunctivitis & Keratitis -- 7-30: Treatment of Ocular Disorders -- 7-31: Principles of Treatment of Ocular Infections -- 7-32: Precautions in Management of Ocular Disorders -- 7-33: Adverse Ocular Effects of Systemic Drugs -- Part 8: Ear, Nose, & Throat Disorders -- 8-01: Hearing Loss -- 8-02: Diseases of the Auricle -- 8-03: Diseases of the Ear Canal -- 8-04: Diseases of the Eustachian Tube -- 8-05: Diseases of the Middle Ear -- 8-06: Earache -- 8-07: Diseases of the Inner Ear -- 8-08: Diseases of the Central Auditory & Vestibular Systems -- 8-09: Otologic Manifestations of AIDS -- 8-10: Infections of the Nose & Paranasal Sinuses -- 8-11: Allergic Rhinitis -- 8-12: Olfactory Dysfunction -- 8-13: Epistaxis -- 8-14: Nasal Trauma -- 8-15: Tumors & Granulomatous Disease -- 8-16: Leukoplakia, Erythroplakia, Oral Lichen Planus, & Oral Cancer -- 8-17: Oral Candidiasis -- 8-18: Glossitis, Glossodynia, Dysgeusia, & Burning Mouth Syndrome -- 8-19: Intraoral Ulcerative Lesions -- 8-20: Pharyngitis & Tonsillitis -- 8-21: Peritonsillar Abscess & Cellulitis -- 8-22: Deep Neck Infections -- 8-23: Snoring -- 8-24: Acute Inflammatory Salivary Gland Disorders -- 8-25: Chronic Inflammatory & Infiltrative Disorders of the Salivary Glands -- 8-26: Salivary Gland Tumors -- 8-27: Dysphonia, Hoarseness, & Stridor -- 8-28: Common Laryngeal Disorders -- 8-29: Masses of the Larynx -- 8-30: Vocal Fold Paralysis -- 8-31: Tracheostomy & Cricothyrotomy -- 8-32: Foreign Bodies of the Trachea & Bronchi -- 8-33: Esophageal Foreign Bodies -- 8-34: Diseases Presenting as Neck Masses -- 8-35: Congenital Lesions Presenting as Neck Masses in Adults -- 8-36: Infectious &
Inflammatory Neck Masses -- 8-37: Tumor Metastases Related to Neck Masses -- 8-38: Lymphoma -- Part 9: Pulmonary Disorders -- 9-01: Approach to the Patient with a Pulmonary Disorders -- 9-02: Disorders of the Airways -- 9-03: Disorders of the Upper Airways -- 9-04: Disorders of the Lower Airways -- 9-05: Approach to Management Asthma -- 9-06: Chronic Obstructive Pulmonary Disease -- 9-07: Bronchiectasis -- 9-08: Allergic Bronchopulmonary Mycosis -- 9-09: Cystic Fibrosis -- 9-10: Bronchiolitis -- 9-11: Pneumonia -- 9-12: Pulmonary Infiltrates in the Immunocompromised Host -- 9-13: Pulmonary Tuberculosis -- 9-14: Pulmonary Disease Caused by Nontuberculous Mycobacteria -- 9-15: Screening for Lung Cancer -- 9-16: Solitary Pulmonary Nodule -- 9-17: Right Middle Lobe Syndrome -- 9-18: Bronchial Carcinoid Tumors -- 9-19: Mediastinal Masses -- 9-20: Interstitial Lung Disease (Diffuse Parenchymal Lung Disease) -- 9-21: Diffuse Interstitial Pneumonias -- 9-22: Sarcoidosis -- 9-23: Pulmonary Alveolar Proteinosis -- 9-24: Eosinophilic Pulmonary Syndromes -- 9-25: Pulmonary Venous Thromboembolism -- 9-26: Pulmonary Hypertension -- 9-27: Pulmonary Vasculitis -- 9-28: Alveolar Hemorrhage Syndromes -- 9-29: Smoke Inhalation -- 9-30: E-cigarette- and vaping product-associated lung injury (EVALI) -- 9-31: Pulmonary Aspiration Syndromes -- 9-32: Occupational Pulmonary Diseases -- 9-33: Medication-Induced Lung Disease -- 9-34: Radiation Lung Injury -- 9-35: Pleuritis -- 9-36: Pleural Effusion -- 9-37: Spontaneous Pneumothorax -- 9-38: Disorders of Control of Ventilation -- 9-39: Hyperventilation Syndromes -- 9-40: Primary Alveolar Hypoventilation -- 9-41: Obesity-Hypoventilation Syndrome (Pickwickian Syndrome) -- 9-42: Sleep-Related Breathing Disorders -- 9-43: Obstructive Sleep Apnea -- 9-44: Acute Respiratory Failure -- 9-45: Acute Respiratory Distress Syndrome -- 9-46: Lung Transplantation -- Part 10: Heart Disease -- 10-01: Heart Disease: Symptoms & Signs -- 10-02: Heart Disease: Diagnostic Testing -- 10-03: Adult Congenital Heart Disease -- 10-04: Pulmonary Valve Stenosis -- 10-05: Coarctation of the Aorta -- 10-06: Atrial Septal Defect & Patent Foramen Ovale -- 10-07: Ventricular Septal Defect -- 10-08: Tetralogy of Fallot -- 10-09: Patent Ductus Arteriosus -- 10-10: Valvular Heart Disease -- 10-11: Mitral Stenosis -- 10-12: Mitral Regurgitation -- 10-13: Mitral Valve Prolapse Syndrome -- 10-14: Aortic Stenosis -- 10-15: Aortic Regurgitation -- 10-16: Tricuspid Stenosis -- 10-17: Tricuspid Regurgitation -- 10-18: Pulmonary Valve Regurgitation -- 10-19: Management of Anticoagulation for Patients with Prosthetic Heart Valves -- 10-20: Coronary Heart Disease (Atherosclerotic CAD, Ischemic Heart Disease) -- 10-21: Chronic Stable Angina Pectoris -- 10-22: Coronary Vasospasm & Angina with Normal Coronary Arteriograms -- 10-23: Acute Coronary Syndromes Without St-Segment Elevation -- 10-24: Acute Myocardial Infarction with St-Segment Elevation -- 10-25: Disorders of Rate & Rhythm -- 10-26: Mechanisms of Arrhythmias -- 10-27: Techniques for Evaluating Rhythm Disturbances -- 10-28: Sinus Arrhythmia, Bradycardia, & Tachycardia -- 10-29: Atrioventicular Block -- 10-30: Paroxysmal Supraventricular Tachycardia (PSVT) -- 10-31: PSVT Due to Accessory AV Pathways (Preexcitation Syndromes) -- 10-32: Atrial Fibrillation -- 10-33: Atrial Flutter -- 10-34: Atrial Tachycardia -- 10-35: Ventricular Premature Beats (Ventricular Extrasystoles) -- 10-36: Ventricular Tachycardia -- 10-37: Ventricular Fibrillation & Sudden Death -- 10-38: Inherited Arrhythmia Syndromes -- 10-39: Syncope -- 10-40: Heart Failure -- 10-41: Acute Heart Failure & Pulmonary Edema -- 10-42: Infectious Myocarditis -- 10-43: Noninfectious Myocarditis -- 10-44: Dilated Cardiomyopathy -- 10-45: Stress Cardiomyopathy -- 10-46: Hypertrophic Cardiomyopathy -- 10-47: Restrictive Cardiomyopathy -- 10-48: Rheumatic Fever -- 10-49: Diseases of the Pericardium: Anatomic & Physiologic Considerations -- 10-50: Acute Inflammatory Pericarditis -- 10-51: Pericardial Effusion & Tamponade -- 10-52: Constrictive Pericarditis -- 10-53: Pulmonary Hypertension & Pulmonary Heart Disease -- 10-54: Pulmonary Heart Disease (Cor Pulmonale) -- 10-55: Primary Cardiac Tumors -- 10-56: Secondary Cardiac Tumors -- 10-57: Cardiac Involvement in Miscellaneous Systemic Diseases -- 10-58: Traumatic Heart Disease -- 10-59: Risk of Noncardiac Surgery in the Cardiac Patient -- 10-60: Heart Disease & Pregnancy -- 10-61: Cardiovascular Changes During Pregnancy -- 10-62: Cardiovascular Complications of Pregnancy -- 10-63: Cardiovascular Screening of Athletes -- Part 11: Systemic Hypertension -- 11-01: Overview: Systemic Hypertension -- 11-02: How is Blood Pressure Measured & Hypertension Diagnosed? -- 11-03: Approach to Hypertension -- 11-04: Drug Therapy: Current Antihypertensive Agents -- 11-05: Resistant Hypertension -- 11-06: Hypertensive Urgencies & Emergencies -- Part 12: Blood Vessel & Lymphatic Disorders -- 12-01: Occlusive Disease: Aorta & Iliac Arteries -- 12-02: Occlusive Disease: Femoral & Popliteal Arteries -- 12-03: Occlusive Disease: Tibial & Pedal Arteries -- 12-04: Acute Arterial Occlusion of a Limb -- 12-05: Occlusive Cerebrovascular Disease -- 12-06: Visceral Artery Insufficiency (Intestinal Angina) -- 12-07: Acute Mesenteric Vein Occlusion -- 12-08: Thromboangiitis Obliterans (Buerger Disease) -- 12-09: Abdominal Aortic Aneurysm -- 12-10: Thoracic Aortic Aneurysms -- 12-11: Peripheral Artery Aneurysms -- 12-12: Aortic Dissection -- 12-13: Varicose Veins -- 12-14: Superficial Venous Thrombophlebitis -- 12-15: Chronic Venous Insufficiency -- 12-16: Superior Vena Caval Obstruction -- 12-17: Lymphangitis & Lymphadenitis -- 12-18: Lymphedema -- 12-19: Shock -- Part 13: Blood Disorders -- 13-01: Anemias -- 13-02: Iron Deficiency Anemia -- 13-03: Anemia of Chronic Disease -- 13-04: The Thalassemias -- 13-05: Sideroblastic Anemia -- 13-06: Vitamin B12 Deficiency -- 13-07: Folic Acid Deficiency -- 13-08: Pure Red Cell Aplasia -- 13-09: Hemolytic Anemias -- 13-10: Hereditary Spherocytosis -- 13-11: Paroxysmal Nocturnal Hemoglobinuria -- 13-12: Glucose-6-Phosphate Dehydrogenase Deficiency -- 13-13: Sickle Cell Anemia & Related Syndromes -- 13-14: Sickle Cell Trait -- 13-15: Sickle Thalassemia -- 13-16: Hemoglobin C Disorders -- 13-17: Unstable Hemoglobins -- 13-18: Autoimmune Hemolytic Anemia -- 13-19: Cold Agglutinin Disease -- 13-20: Microangiopathic Hemolytic Anemias -- 13-21: Aplastic Anemia -- 13-22: Neutropenia -- 13-23: Leukemias & Other Myeloproliferative Neoplasms -- 13-24: Polycythemia Vera -- 13-25: Essential Thrombocytosis -- 13-26: Primary Myelofibrosis -- 13-27: Chronic Myeloid Leukemia -- 13-28: Myelodysplastic Syndromes -- 13-29: Acute Leukemia -- 13-30: Chronic Lymphocytic Leukemia -- 13-31: Hairy Cell Leukemia -- 13-32: Non-Hodgkin Lymphomas -- 13-33: Hodgkin Lymphoma -- 13-34: Plasma Cell Myeloma -- 13-35: Monoclonal Gammopathy of Undetermined Significance -- 13-36: Waldenstro?m Macroglobulinemia -- 13-37: Amyloidosis -- 13-38: Stem Cell & Immune Cell Therapeutics -- 13-39: Red Blood Cell Transfusions -- 13-40: Platelet Transfusions -- 13-41: Transfusion of Plasma Components -- Part 14: Disorders of Hemostasis, Thrombosis, & Antithrombotic Therapy -- 14-01: Overview of Hemostasis -- 14-02: Thrombocytopenia -- 14-03: Decreased Platelet Production -- 14-04: Increased Platelet Destruction -- 14-05: Other Conditions Causing Thrombocytopenia -- 14-06: Congenital Disorders of Platelet Function -- 14-07: Acquired Disorders of Platelet Function -- 14-08: Congenital Disorders of Coagulation -- 14-09: Acquired Disorders of Coagulation -- 14-10: Other Causes of Bleeding -- 14-11: Antithrombotic Therapy -- Part 15: Gastrointestinal Disorders -- 15-01: Dyspepsia -- 15-02: Nausea & Vomiting -- 15-03: Hiccups -- 15-04: Constipation -- 15-05: Gastrointestinal Gas -- 15-06: Diarrhea -- 15-07: Gastrointestinal Bleeding -- 15-08:
Assessment of the Patient with Ascites -- 15-09: Spontaneous Bacterial Peritonitis -- 15-10: Malignant Ascites -- 15-11: Familial Mediterranean Fever -- 15-12: Mesothelioma -- 15-13: Miscellaneous Peritoneal Diseases -- 15-14: Diseases of the Esophagus -- 15-15: Gastroesophageal Reflux Disease -- 15-16: Infectious Esophagitis -- 15-17: Pill-Induced Esophagitis -- 15-18: Caustic Esophageal Injury -- 15-19: Benign Esophageal Lesions -- 15-20: Esophageal Motility Disorders -- 15-21: Chest Pain of Undetermined Origin -- 15-22: Gastritis & Gastropathy -- 15-23: Peptic Ulcer Disease -- 15-24: Complications of Peptic Ulcer Disease -- 15-25: Zollinger-Ellison Syndrome (Gastrinoma) -- 15-26: Benign Tumors of the Stomach -- 15-27: Malabsorption -- 15-28: Intestinal Motility Disorders -- 15-29: Benign Tumors of the Small Intestine -- 15-30: Appendicitis -- 15-31: Intestinal Tuberculosis -- 15-32: Protein-Losing Enteropathy -- 15-33: Irritable Bowel Syndrome -- 15-34: Antibiotic-Associated Colitis -- 15-35: Inflammatory Bowel Disease -- 15-36: Diverticular Disease of the Colon -- 15-37: Polyps of the Colon -- 15-38: Nonfamilial Adenomatous & Serrated Polyps -- 15-39: Hereditary Colorectal Cancer & Polyposis Syndromes -- 15-40: Hemorrhoids -- 15-41: Anorectal Infections -- 15-42: Rectal Prolapse & Solitary Rectal Ulcer Syndrome -- 15-43: Fecal Incontinence -- 15-44: Other Anal Conditions: Fissures, Abscess, Pruritus -- Part 16: Liver, Biliary Tract, & Pancreas Disorders -- 16-01: Jaundice & Evaluation of Abnormal Liver Biochemical Tests -- 16-02: Acute Hepatitis A -- 16-03: Acute Hepatitis B -- 16-04: Acute Hepatitis C & Other Causes of Acute Viral Hepatitis -- 16-05: Acute Liver Failure -- 16-06: Chronic Viral Hepatitis -- 16-07: Autoimmune Hepatitis -- 16-08: Alcohol-Associated Liver Disease -- 16-09: Drug- & Toxin-Induced Liver Injury -- 16-10: Nonalcoholic Fatty Liver Disease -- 16-11: Cirrhosis -- 16-12: Primary Biliary Cholangitis -- 16-13: Hemochromatosis -- 16-14: Wilson Disease -- 16-15: Hepatic Venous Outflow Obstruction (Budd-Chiari Syndrome) -- 16-16: The Liver in Heart Failure -- 16-17: Noncirrhotic Portal Hypertension -- 16-18: Pyogenic Hepatic Abscess -- 16-19: Benign Liver Neoplasms -- 16-20: Cholelithiasis (Gallstones) -- 16-21: Acute Cholecystitis -- 16-22: Pre- & Postcholecystectomy Syndromes -- 16-23: Choledocholithiasis & Cholangitis -- 16-24: Biliary Stricture -- 16-25: Primary Sclerosing Cholangitis -- 16-26: Acute Pancreatitis -- 16-27: Chronic Pancreatitis -- Part 17: Breast Disorders -- 17-01: Fibrocystic Condition -- 17-02: Fibroadenoma of the Breast -- 17-03: Nipple Discharge -- 17-04: Fat Necrosis -- 17-05: Breast Abscess -- 17-06: Disorders of the Augmented Breast -- 17-07: Carcinoma of the Female Breast -- 17-08: Carcinoma of the Male Breast -- Part 18: Gynecologic Disorders -- 18-01: Premenopausal Abnormal Uterine Bleeding -- 18-02: Postmenopausal Uterine Bleeding -- 18-03: Leiomyoma of the Uterus (Fibroid Tumor) -- 18-04: Cervical Polyps -- 18-05: Endometriosis -- 18-06: Pelvic Pain -- 18-07: Pelvic Organ Prolapse -- 18-08: Premenstrual Syndrome -- 18-09: Menopausal Syndrome -- 18-10: Polycystic Ovary Syndrome -- 18-11: Infertility -- 18-12: Contraception -- 18-13: Female Sexual Dysfunction -- 18-14: Sexual Violence -- 18-15: Bartholin Duct Cysts & Abscesses -- 18-16: Vaginitis -- 18-17: Pelvic Inflammatory Disease (Salpingitis, Endometritis) -- 18-18: Condyloma Acuminata -- 18-19: Cervical Intraepithelial Neoplasia (CIN) (Dysplasia of the Cervix) -- 18-20: Carcinoma of the Cervix -- 18-21: Carcinoma of the Endometrium -- 18-22: Carcinoma of the Vulva -- 18-23: Ovarian Cancer & Ovarian Tumors -- Part 19: Obstetrics & Obstetric Disorders -- 19-01: Diagnosis of Pregnancy -- 19-02: Essentials of Prenatal Care -- 19-03: Nutrition in Pregnancy -- 19-04: Prevention of Rhesus Alloimmunization -- 19-05: Lactation -- 19-06: Travel & Immunizations During Pregnancy -- 19-07: Vomiting of Pregnancy & Hyperemesis Gravidarum -- 19-08: Spontaneous Abortion -- 19-09: Recurrent Abortion -- 19-10: Ectopic Pregnancy -- 19-11: Gestational Trophoblastic Disease (Hydatidiform Mole & Choriocarcinoma) -- 19-12: Preeclampsia-Eclampsia -- 19-13: Preterm Labor -- 19-14: Third-Trimester Bleeding -- 19-15: Puerperal Mastitis -- 19-16: Chorioamnionitis & Metritis -- 19-17: Anemia in Pregnancy -- 19-18: Antiphospholipid Syndrome in Pregnancy -- 19-19: Thyroid Disease in Pregnancy -- 19-20: Diabetes Mellitus in Pregnancy -- 19-21: Chronic Hypertension in Pregnancy -- 19-22: Heart Disease in Pregnancy -- 19-23: Asthma in Pregnancy -- 19-24: Seizure Disorders in Pregnancy -- 19-25: Urinary Tract Infection in Pregnancy -- 19-26: Group B Streptococcal Infection in Pregnancy -- 19-27: Varicella in Pregnancy -- 19-28: Tuberculosis in Pregnancy -- 19-29: HIV/AIDS During Pregnancy -- 19-30: Maternal Hepatitis B & C Carrier State -- 19-31: Herpes Genitalis in Pregnancy -- 19-32: Syphilis, Gonorrhea, & Chlamydia Trachomatis Infection in Pregnancy -- 19-33: Gastrointestinal, Hepatic, & Biliary Disorders of Pregnancy -- 19-34: Cholelithiasis & Cholecystitis in Pregnancy -- 19-35: Acute Fatty Liver of Pregnancy -- 19-36: Intrahepatic Cholestasis of Pregnancy -- 19-37: Appendicitis in Pregnancy -- 19-38: Carcinoma of the Breast in Pregnancy -- 19-39: Ovarian Tumors in Pregnancy -- Part 20: Rheumatologic, Immunologic, & Allergic Disorders -- 20-01: Rheumatologic Disorders -- 20-02: Degenerative Joint Disease (Osteoarthritis) -- 20-03: Crystal Deposition Arthritis -- 20-04: Autoimmune Diseases -- 20-05: Rheumatoid Arthritis -- 20-06: Adult Still Disease -- 20-07: Systemic Lupus Erythematosus -- 20-08: Drug-Induced Lupus -- 20-09: Antiphospholipid Syndrome -- 20-10: Raynaud Phenomenon -- 20-11: Scleroderma (Systemic Sclerosis) -- 20-12: Idiopathic Inflammatory Myopathies (Polymyositis & Dermatomyositis) -- 20-13: Mixed Connective Tissue Disease & Overlap Syndromes -- 20-14: Sjo?gren Syndrome -- 20-15: IgG4-Related Disease -- 20-16: Vasculitis Syndromes -- 20-17: Polymyalgia Rheumatica & Giant Cell Arteritis -- 20-18: Takayasu Arteritis -- 20-19: Polyarteritis Nodosa -- 20-20: Granulomatosis with Polyangiitis -- 20-21: Microscopic Polyangiitis -- 20-22: Eosinophilic Granulomatosis with Polyangiitis -- 20-23: Levamisole-Associated Purpura -- 20-24: Cryoglobulinemia -- 20-25: IgA Vasculitis -- 20-26: Relapsing Polychondritis -- 20-27: Behc偈et Syndrome -- 20-28: Primary Angiitis of the Central Nervous System -- 20-29: Livedo Reticularis & Livedo Racemosa -- 20-30: Seronegative Spondyloarthropathies -- 20-31: Ankylosing Spondylitis -- 20-32: Psoriatic Arthritis -- 20-33: Reactive Arthritis -- 20-34: Inflammatory Bowel Disease Associated Spondyloarthritis -- 20-35: Nongonococcal Acute Bacterial (Septic) Arthritis -- 20-36: Gonococcal Arthritis -- 20-37: Rheumatic Manifestations of HIV Infection -- 20-38: Viral Arthritis -- 20-39: Acute Pyogenic Osteomyelitis -- 20-40: Mycotic Infections of Bones & Joints -- 20-41: Spinal Tuberculosis (Pott Disease) -- 20-42: Tuberculous Arthritis -- 20-43: Arthritis In Sarcoidosis -- 20-44: Tumors & Tumor-Like Lesions of Bone -- 20-45: Thoracic Outlet Syndromes -- 20-46: Fibromyalgia -- 20-47: Complex Regional Pain Syndrome -- 20-48: Rheumatologic Manifestations of Cancer -- 20-49: Neurogenic Arthropathy (Charcot Joint) -- 20-50: Palindromic Rheumatism -- 20-51: Osteonecrosis (Avascular Necrosis of Bone) -- 20-52: Some Orthopedic Procedures for Arthritic Joints -- 20-53: Allergic & Immunologic Disorders -- 20-54: Immediate Hypersensitivity -- 20-55: Allergy Testing -- 20-56: Delayed Hypersensitivity -- 20-57: Primary Immunodeficiency Disorders in Adults -- Part 21: Electrolyte & Acid-Base Disorders -- 21-01: Assessment of the Patient for Electrolyte and Fluid Disorders -- 21-02: Hyponatremia -- 21-03: Hypernatremia -- 21-04: Hypokalemia -- 21-05: Hyperkalemia -- 21-06: Disorders of Calcium Concentration -- 21-07: Hypocalcemia -- 21-08:
Hypercalcemia -- 21-09: Disorders of Phosphorus Concentration -- 21-10: Hypophosphatemia -- 21-11: Hyperphosphatemia -- 21-12: Disorders of Magnesium Concentration -- 21-13: Hypomagnesemia -- 21-14: Hypermagnesemia -- 21-15: Acid-Base Disorders -- 21-16: Mixed Acid-Base Disorders -- 21-17: Metabolic Acidosis -- 21-18: Increased Anion Gap Acidosis -- 21-19: Normal Anion Gap Acidosis -- 21-20: Metabolic Alkalosis -- 21-21: Respiratory Acidosis (Hypercapnia) -- 21-22: Respiratory Alkalosis -- 21-23: Fluid Management -- Part 22: Kidney Disease -- 22-01: Overview: Kidney Disease -- 22-02: Assessment of Kidney Disease -- 22-03: Imaging Studies of the Kidney -- 22-04: Kidney Biopsy -- 22-05: Acute Kidney Injury -- 22-06: Acute Tubular Necrosis -- 22-07: Rhabdomyolysis -- 22-08: Interstitial Nephritis -- 22-09: Glomerulonephritis -- 22-10: Cardiorenal Syndrome -- 22-11: Chronic Kidney Disease -- 22-12: Renal Artery Stenosis -- 22-13: Glomerular Diseases -- 22-14: Nephritic Spectrum Glomerular Diseases -- 22-15: Nephrotic Spectrum Glomerular Diseases -- 22-16: Minimal Change Disease -- 22-17: Focal Segmental Glomerulosclerosis -- 22-18: Membranous Nephropathy -- 22-19: Diabetic Nephropathy -- 22-20: HIV-Associated Nephropathy -- 22-21: Renal Amyloidosis -- 22-22: Tubulointerstitial Diseases -- 22-23: Chronic Tubulointerstitial Diseases -- 22-24: Cystic Diseases of the Kidney -- 22-25: Simple or Solitary Cysts of the Kidney -- 22-26: Autosomal Dominant Polycystic Kidney Disease -- 22-27: Medullary Sponge Kidney -- 22-28: Juvenile Nephronophthisis-Medullary Cystic Disease -- 22-29: Plasma Cell Myeloma -- 22-30: Renal Manifestations of Tuberculosis -- 22-31: Renal Manifestations of Tuberculosis -- 22-32: Gout & The Kidney -- 22-33: Nephrogenic Systemic Fibrosis -- 22-34: The Kidney & Aging -- Part 23: Urologic Disorders -- 23-01: Urologic Evaluation -- 23-02: Hematuria -- 23-03: Genitourinary Tract Infections -- 23-04: Interstitial Cystitis -- 23-05: Urinary Stone Disease -- 23-06: Male Erectile Dysfunction & Sexual Dysfunction -- 23-07: Male Infertility -- 23-08: Benign Prostatic Hyperplasia -- Part 24: Nervous System Disorders -- 24-01: Headache -- 24-02: Facial Pain -- 24-03: Epilepsy -- 24-04: Dysautonomia -- 24-05: Sensory Disturbances -- 24-06: Weakness & Paralysis -- 24-07: Transient Ischemic Attacks -- 24-08: Stroke -- 24-09: Intracranial & Spinal Mass Lesions -- 24-10: Nonmetastatic Neurologic Complications of Malignant Disease -- 24-11: Idiopathic Intracranial Hypertension (Pseudotumor Cerebri) -- 24-12: Selected Neurocutaneous Diseases -- 24-13: Movement Disorders -- 24-14: Dementia -- 24-15: Wernicke Encephalopathy & Korsakoff Syndrome -- 24-16: Stupor & Coma -- 24-17: Head Injury -- 24-18: Multiple Sclerosis -- 24-19: Neuromyelitis Optica -- 24-20: Vitamin E Deficiency -- 24-21: Spasticity -- 24-22: Myelopathies in AIDS -- 24-23: Myelopathy of Human T-Cell Leukemia Virus Infection -- 24-24: Subacute Combined Degeneration of the Spinal Cord -- 24-25: Spinal Trauma -- 24-26: Syringomyelia -- 24-27: Degenerative Motor Neuron Diseases -- 24-28: Peripheral Neuropathies -- 24-29: Polyneuropathies & Mononeuritis Multiplex -- 24-30: Mononeuropathies -- 24-31: Bell Palsy -- 24-32: Discogenic Neck Pain -- 24-33: Brachial & Lumbar Plexus Lesions -- 24-34: Disorders Of Neuromuscular Transmission -- 24-35: Myopathic Disorders -- 24-36: Periodic Paralysis Syndromes -- Part 25: Psychiatric Disorders -- 25-01: Psychiatric Assessment -- 25-02: Treatment Approaches for Psychiatric Treatment Disorders -- 25-03: Psychiatric Adjustment Disorders -- 25-04: Psychiatric Trauma & Stressor-Related Disorders -- 25-05: Anxiety Disorders -- 25-06: Obsessive-Compulsive Disorder & Related Disorders -- 25-07: Somatic Symptom Disorders (Abnormal Illness Behaviors) -- 25-08: Chronic Pain Disorders -- 25-09: Psychosexual Disorders -- 25-10: Personality Disorders -- 25-11: Schizophrenia Spectrum Disorders -- 25-12: Mood Disorders (Depression & Mania) -- 25-13: Attention-Deficit/Hyperactivity Disorder -- 25-14: Autism Spectrum Disorders -- 25-15: Sleep-Wake Disorders -- 25-16: Disorders of Aggression -- 25-17: Substance Use Disorders -- 25-18: Alcohol Use Disorder (Alcoholism) -- 25-19: Other Drug & Substance Use Disorders -- 25-20: Neurocognitive Disorders -- 25-21: Psychiatric Problems Associated with Hospitalization & Illness -- Part 26: Endocrine Disorders -- 26-01: Anterior Hypopituitarism -- 26-02: Central Diabetes Insipidus -- 26-03: Acromegaly & Gigantism -- 26-04: Hyperprolactinemia -- 26-05: Nonfunctioning Pituitary Adenomas -- 26-06: Thyroid Testing -- 26-07: Thyroiditis -- 26-08: Hypothyroidism & Myxedema -- 26-09: Hyperthyroidism (Thyrotoxicosis) -- 26-10: Thyroid Nodules & Multinodular Goiter -- 26-11: Thyroid Cancer -- 26-12: Iodine Deficiency Disorder & Endemic Goiter -- 26-13: Diseases of the Parathyroids -- 26-14: Hypoparathyroidism & Pseudohypoparathyroidism -- 26-15: Hyperparathyroidism -- 26-16: Metabolic Bone Disease -- 26-17: Osteopenia -- 26-18: Osteoporosis -- 26-19: Rickets & Osteomalacia -- 26-20: Paget Disease of Bone (Osteitis Deformans) -- 26-21: Primary Adrenal Insufficiency (Addison Disease) -- 26-22: Cushing Syndrome (Hypercortisolism) -- 26-23: Primary Aldosteronism -- 26-24: Pheochromocytoma & Paraganglioma -- 26-25: Incidentally Discovered Adrenal Masses -- 26-26: Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETS) & Carcinoid Tumors -- 26-27: Men Types 1-4 -- 26-28: Other Syndromes of Multiple Endocrine Neoplasia -- 26-29: Male Hypogonadism -- 26-30: Cryptorchism -- 26-31: Gynecomastia -- 26-32: Hirsutism & Virilization -- 26-33: Primary Amenorrhea -- 26-34: Secondary Amenorrhea & Menopause -- 26-35: Turner Syndrome (Gonadal Dysgenesis) -- 26-36: Clinical use of Corticosteroids -- Part 27: Diabetes Mellitus & Hypoglycemia -- 27-01: Diabetes Mellitus -- 27-02: Diabetic Coma -- 27-03: Diabetic Ketoacidosis -- 27-04: Hyperglycemic Hyperosmolar State -- 27-05: Lactic Acidosis -- 27-06: The Hypoglycemic States -- 27-07: Hypoglycemia Due to Pancreatic B Cell Tumors -- 27-08: Nonislet Cell Tumor Hypoglycemia -- 27-09: Postprandial Hypoglycemia -- 27-10: Factitious Hypoglycemia -- 27-11: Hypoglycemia Due to Insulin Receptor Antibodies -- 27-12: Medication- & Ethanol-Induced Hypoglycemia; was Medication-Induced Hypoglycemia -- Part 28: Lipid Disorders -- 28-01: Overview: Lipid Disorders -- 28-02: Lipids & Lipoproteins -- 28-03: Lipoproteins & Atherogenesis -- 28-04: Lipid Fractions & the Risk of Coronary Heart Disease -- 28-05: Therapeutic Effects of Lowering Cholesterol -- 28-06: Secondary Conditions that Affect Lipid Metabolism -- 28-07: Lipid Disorders: Clinical Presentations -- 28-08: Screening & Treatment Of High Blood Cholesterol -- 28-09: Treatment of High LDL Cholesterol -- 28-10: High Blood Triglycerides -- Part 29: Nutritional Disorders -- 29-01: Nutritional Requirements -- 29-02: Assessment of Nutritional Status -- 29-03: Protein-Energy Malnutrition -- 29-04: Obesity -- 29-05: Anorexia Nervosa -- 29-06: Bulimia Nervosa -- 29-07: Disorders of Vitamin Metabolism -- 29-08: Thiamine (B1) Deficiency -- 29-09: Thiamine Toxicity -- 29-10: Riboflavin (B2) Deficiency -- 29-11: Riboflavin Toxicity -- 29-12: Niacin Deficiency -- 29-13: Niacin Toxicity -- 29-14: Vitamin B6 Deficiency -- 29-15: Vitamin B6 Toxicity -- 29-16: Vitamin C (Ascorbic Acid) Deficiency -- 29-17: Vitamin C Toxicity -- 29-18: Vitamin A Deficiency -- 29-19: Vitamin A Toxicity -- 29-20: Vitamin E Deficiency -- 29-21: Vitamin E Toxicity -- 29-22: Diet Therapy -- 29-23: Diets that Alter Consistency -- 29-24: Diets that Restrict Nutrients -- 29-25: Diets that Supplement Nutrients -- 29-26: Nutritional Support -- 29-27: Indications for Nutritional Support -- 29-28: Nutritional Requirements -- 29-29: Enteral Nutritional Support Solutions -- 29-30: Complications of Enteral Nutritional Support -- 29-31: Parenteral Nutritional Support Solutions -- 29-32: Complications of
Parenteral Nutritional Support -- 29-33: Patient Monitoring During Nutritional Support -- Part 30: Common Problems in Infectious Diseases & Antimicrobial Therapy -- 30-01: Fever of Unknown Origin (FUO) -- 30-02: Infections in the Immunocompromised Patient -- 30-03: Health Care-Associated Infections -- 30-04: Infections of the Central Nervous System -- 30-05: Animal & Human Bite Wounds -- 30-06: Sexually Transmitted Diseases -- 30-07: Infections in Persons who Inject Drugs -- 30-08: Acute Infectious Diarrhea -- 30-09: Infectious Diseases in the Returning Traveler -- 30-10: Traveler's Diarrhea -- 30-11: Selected Principles of Antimicrobial Therapy -- 30-12: Hypersensitivity -- 30-13: Recommended Immunization of Infants, Children, & Adolescents -- 30-14: Recommended Immunization for Adults -- 30-15: Recommended Immunizations for Travelers -- 30-16: Vaccine Safety -- Part 31: HIV Infection & AIDS -- 31-01: Overview: HIV Infection & AIDS -- 31-02: HIV Infection & AIDS: Clinical Findings -- 31-03: HIV Infection & AIDS: Differential Diagnosis -- 31-04: HIV Infection & AIDS: Complications -- 31-05: HIV Infection & AIDS: Prevention -- 31-06: HIV Infection & AIDS: Treatment -- 31-07: HIV Infection & AIDS: Course & Prognosis -- Part 32: Viral & Rickettsial Infections -- 32-01: Human Herpesviruses -- 32-02: Major Vaccine-Preventable Viral Infections -- 32-03: Other Neurotropic Viruses -- 32-04: Viral Hemorrhagic Fevers -- 32-05: Other Systemic Viral Diseases -- 32-06: Common Viral Respiratory Infections -- 32-07: Adenovirus Infections -- 32-08: Other Exanthematous Viral Infections -- 32-09: Viruses & Gastroenteritis -- 32-10: Enteroviruses that Produce Several Syndromes -- 32-11: Typhus Group -- 32-12: Spotted Fevers -- 32-13: Other Rickettsial & Rickettsial-Like Diseases -- 32-14: Kawasaki Disease -- Part 33: Bacterial & Chlamydial Infections -- 33-01: Streptococcal Infections -- 33-02: Enterococcal Infections -- 33-03: Pneumococcal Infections -- 33-04: Staphylococcus Aureus Infections -- 33-05: Clostridial Diseases -- 33-06: Anthrax -- 33-07: Diphtheria -- 33-08: Listeriosis -- 33-09: Infective Endocarditis -- 33-10: Bordetella Pertussis Infection (Whooping Cough) -- 33-11: Other Bordetella Infections -- 33-12: Meningococcal Meningitis -- 33-13: Infections Caused by Haemophilus Species -- 33-14: Infections Caused by Moraxella Catarrhalis -- 33-15: Legionnaires Disease -- 33-16: Gram-Negative Bacteremia & Sepsis -- 33-17: Salmonellosis -- 33-18: Shigellosis -- 33-19: Gastroenteritis Caused by Escherichia Coli -- 33-20: Cholera -- 33-21: Infections Caused by Other Vibrio Species -- 33-22: Infections Caused by Campylobacter Species -- 33-23: Brucellosis -- 33-24: Tularemia -- 33-25: Plague -- 33-26: Gonococcal Infections -- 33-27: Chancroid -- 33-28: Granuloma Inguinale -- 33-29: Bartonella Species -- 33-30: Elizabethkingia Species -- 33-31: Anaerobic Infections -- 33-32: Procalcitonin -- 33-33: Actinomycosis -- 33-34: Nocardiosis -- 33-35: Nontuberculous Mycobacterial Diseases -- 33-36: Mycobacterium Tuberculosis Infections -- 33-37: Tuberculous Meningitis -- 33-38: Leprosy (Hansen Disease) -- 33-39: Infections Caused by Chlamydiae -- 33-40: Chlamydia Trachomatis Infections -- 33-41: Chlamydophila Psittaci & Psittacosis (Ornithosis) -- 33-42: Chlamydophila Pneumoniae Infection -- Part 34: Spirochetal Infections -- 34-01: Syphilis: Natural History & Principles of Diagnosis & Treatment... -- 34-02: Syphilis: Course & Prognosis -- 34-03: Clinical Stages of Syphilis -- 34-04: Non-Sexually Transmitted Treponematoses -- 34-05: Yaws -- 34-06: Pinta -- 34-07: Endemic Syphilis (Bejel) -- 34-08: Relapsing Fever -- 34-09: Rat-Bite Fever -- 34-10: Leptospirosis -- 34-11: Lyme Disease (Lyme Borreliosis) -- 34-12: Borrelia Miyamotoi Disease -- Part 35: Protozoal & Helminthic Infections -- 35-01: African Trypanosomiasis (Sleeping Sickness) -- 35-02: American Trypanosomiasis (Chagas Disease) -- 35-03: Leishmaniasis -- 35-04: Malaria -- 35-05: Babesiosis -- 35-06: Toxoplasmosis -- 35-07: Amebiasis -- 35-08: Infections with Pathogenic Free-Living Amoebas -- 35-09: Coccidiosis (Cryptosporidiosis, Isosporiasis, Cyclosporiasis, Sarcocystosis) & Microsporidiosis -- 35-10: Giardiasis -- 35-11: Other Intestinal Flagellate Infections -- 35-12: Trichomoniasis -- 35-13: Schistosomiasis (Bilharziasis) -- 35-14: Fascioliasis -- 35-15: Clonorchiasis & Opisthorchiasis -- 35-16: Paragonimiasis -- 35-17: Intestinal Flukes -- 35-18: Noninvasive Cestode Infections -- 35-19: Invasive Cestode Infections -- 35-20: Ascariasis -- 35-21: Trichuriasis -- 35-22: Hookworm Disease -- 35-23: Strongyloidiasis -- 35-24: Enterobiasis -- 35-25: Dracunculiasis -- 35-26: Trichinosis -- 35-27: Angiostrongyliasis -- 35-28: Gnathostomiasis -- 35-29: Toxocariasis -- 35-30: Cutaneous Larva Migrans (Creeping Eruption) -- 35-31: Anisakiasis -- 35-32: Lymphatic Filariasis -- 35-33: Onchocerciasis -- 35-34: Loiasis -- Part 36: Mycotic Infections -- 36-01: Overview: Mycotic Infections -- 36-02: Candidiasis -- 36-03: Histoplasmosis -- 36-04: Coccidioidomycosis -- 36-05: Pneumocystosis (Pneumocystis jirovecii Pneumonia) -- 36-06: Cryptococcosis -- 36-07: Aspergillosis -- 36-08: Mucormycosis -- 36-09: Blastomycosis -- 36-10: Paracoccidioidomycosis (South American Blastomycosis) -- 36-11: Sporotrichosis -- 36-12: Talaromyces (Formerly Penicillium) Marneffei Infections -- 36-13: Chromoblastomycosis (Chromomycosis) -- 36-14: Mycetoma (Eumycetoma & Actinomycetoma) -- 36-15: Other Opportunistic Mold Infections -- 36-16: Household Molds -- 36-17: Antifungal Therapy -- Part 37: Disorders Related to Environmental Emergencies -- 37-01: Cold & Heat -- 37-02: Disorders Due to Heat -- 37-03: Accidental Systemic Hypothermia -- 37-04: Hypothermia of the Extremities -- 37-05: Frostnip & Chilblain (Erythema Pernio) -- 37-06: Immersion Foot or Trench Foot -- 37-07: Frostbite -- 37-08: Cold Urticaria -- 37-09: Drowning -- 37-10: Thermal Burns -- 37-11: Electrical Injury -- 37-12: Radiation Exposure -- 37-13: Dysbarism & Decompression Sickness -- 37-14: High-Altitude Illness -- 37-15: Safety of Air Travel & Selection of Patients for Air Travel -- Part 38: Poisoning -- 38-01: Initial Evaluation: Poisoning or Overdose -- 38-02: Poisoning or Overdose: The Symptomatic Patient -- 38-03: Poisoning or Overdose-Related Coma -- 38-04: Poisoning or Overdose-Related Hypothermia -- 38-05: Poisoning or Overdose-Related Hypotension -- 38-06: Poisoning or Overdose-Related Hypertension -- 38-07: Poisoning or Overdose-Related Arrhythmias -- 38-08: Poisoning or Overdose-Related Seizures -- 38-09: Poisoning or Overdose-Related Hyperthermia -- 38-10: Antidotes -- 38-11: Decontamination of the Skin -- 38-12: Decontamination of the Eyes -- 38-13: Gastrointestinal Decontamination -- 38-14: Diagnosis of Poisoning -- 38-15: Acetaminophen Overdose -- 38-16: Acids, Corrosive Poisoning -- 38-17: Alkalies Poisoning -- 38-18: Amphetamines & Cocaine Overdose -- 38-19: Anticoagulants Overdose -- 38-20: Anticonvulsants Overdose -- 38-21: Antipsychotic Drug Overdose -- 38-22: Arsenic Poisoning -- 38-23: Atropine & Anticholinergics Overdose -- 38-24: Beta-Adrenergic Blockers Overdose -- 38-25: Calcium Channel Blockers Overdose -- 38-26: Carbon Monoxide Poisoning -- 38-27: Chemical Warfare: Nerve Agents -- 38-28: Chemical Warfare: Ricin -- 38-29: Chlorinated Insecticides Posioning -- 38-30: Clonidine & Other Sympatholytic Antihypertensives Overdose -- 38-31: Cyanide Poisoning -- 38-32: Dietary Supplements & Herbal Products Overdose -- 38-33: Digitalis & Other Cardiac Glycosides Overdose -- 38-34: Ethanol, Benzodiazepines, & Other Sedative-Hypnotic Agents Overdose -- 38-35: Gamma-Hydroxybutyrate (GHB) Overdose -- 38-36: Hypoglycemic Drugs Overdose -- 38-37: Iron Overdose -- 38-38: Isoniazid Overdose -- 38-39: Lead Poisoning -- 38-40: Lithium Poisoning -- 38-41: LSD & Other Hallucinogens Overdose -- 38-42: Marijuana & Synthetic Cannabinoids --
38-43: Mercury Poisoning -- 38-44: Methanol & Ethylene Glycol Poisoning -- 38-45: Methemoglobinemia-Inducing Agents Poisoning -- 38-46: Monoamine Oxidase Inhibitors Overdose -- 38-47: Mushroom Poisoning -- 38-48: Opiate & Opioid Overdose -- 38-49: Paraquat Poisoning -- 38-50: Pesticides: Cholinesterase Inhibitors Poisoning -- 38-51: Petroleum Distillates & Solvents Poisoning -- 38-52: Quinidine & Related Antiarrhythmics Overdose -- 38-53: Salicylates Overdose -- 38-54: Seafood Poisonings -- 38-55: Snake Bites -- 38-56: Spider Bites & Scorpion Stings -- 38-57: Theophylline & Caffeine Overdose -- 38-58: Tricyclic & Other Antidepressants Overdose -- Part 39: Cancer -- 39-01: Introduction to Cancer -- 39-02: The Paraneoplastic Syndromes -- 39-03: Bronchogenic Carcinoma -- 39-04: Pulmonary Metastasis -- 39-05: Mesothelioma -- 39-06: Hepatocellular Carcinoma -- 39-07: Carcinoma of the Biliary Tract -- 39-08: Carcinoma of the Pancreas & Ampulla of Vater -- 39-09: Esophageal Cancer -- 39-10: Gastric Adenocarcinoma -- 39-11: Gastric Lymphoma -- 39-12: Gastric Neuroendocrine Tumors -- 39-13: Gastrointestinal Mesenchymal Tumors -- 39-14: Malignancies of the Small Intestine -- 39-15: Colorectal Cancer -- 39-16: Carcinoma of the Anus -- 39-17: Prostate Cancer -- 39-18: Bladder Cancer -- 39-19: Cancers of the Ureter & Renal Pelvis -- 39-20: Renal Cell Carcinoma -- 39-21: Other Primary Tumors of the Kidney -- 39-22: Secondary Cancers of the Kidney -- 39-23: Testicular Cancers (Germ Cell Tumors) -- 39-24: Secondary Cancers of the Testis -- 39-25: Cancer-Related Spinal Cord Compression -- 39-26: Malignant Effusions -- 39-27: Cancer-Related Hypercalcemia -- 39-28: Hyperuricemia & Tumor Lysis Syndrome -- 39-29: Infections in Cancer Patients -- 39-30: Systemic Cancer Therapy -- 39-31: Toxicity & Dose Modification of Chemotherapeutic Agents -- 39-32: Prognosis in Patients Receiving Chemotherapy -- Part 40: Genetic & Genomic Disorders -- 40-01: Overview: Genetic & Genomic Disorders -- 40-02: Genes & Chromosomes -- 40-03: Gene Mutation -- 40-04: Genes in Individuals -- 40-05: Genes in Families -- 40-06: Genetics in Disorders of Multifactorial Causation -- 40-07: Chromosomal Aberrations -- 40-08: The Techniques of Medical Genetics -- 40-09: Cytogenetics & Cytogenomics -- 40-10: Biochemical Genetics -- 40-11: DNA Analysis -- 40-12: Prenatal Diagnosis of Genetic Disorders -- 40-13: Neoplasia: Cytogenomic & DNA Analysis -- 40-14: Evolution of Gene Therapy -- 40-15: Acute Intermittent Porphyria -- 40-16: Down Syndrome -- 40-17: Familial Hypercholesterolemia -- 40-18: Fragile X Mental Retardation -- 40-19: Gaucher Disease -- 40-20: Disorders of Homocysteine Metabolism -- 40-21: Klinefelter Syndrome -- 40-22: Marfan Syndrome -- 40-23: Hereditary Hemorrhagic Telangiectasia -- Part 41: Sports Medicine & Outpatient Orthopedics -- 41-01: General Approach to Musculoskeletal Injuries -- 41-02: Musculoskeletal Injuries of the Shoulder -- 41-03: Spine Problems -- 41-04: Upper Extremity Musculoskeletal Injuries -- 41-05: Musculoskeletal Injuries of the Hip -- 41-06: Musculoskeletal Injuries of the Knee -- 41-07: Ankle Injuries -- Part 42: Lesbian, Gay, Bisexual, & Transgender Health -- 42-01: Health Care for Sexual & Gender Minority Patients -- 42-02: Health Care for Lesbian & Bisexual Women -- 42-03: Health Care for Gay & Bisexual Men -- 42-04: Transgender Health & Disease Prevention -- Part e1: Anti-Infective Chemotherapeutic & Antibiotic Agents -- e1-01: Penicillins -- e1-02: Cephalosporins -- e1-03: Other Beta-Lactam Medications -- e1-04: Erythromycin Group (Macrolides) -- e1-05: Tetracycline Group -- e1-06: Tetracycline Derivatives -- e1-07: Aminoglycosides -- e1-08: Polymyxins -- e1-09: Lefamulin -- e1-10: Antituberculous Medications -- e1-11: Alternative Medications in Tuberculosis Treatment -- e1-12: Rifamycins -- e1-13: Sulfonamides & Antifolate Medications -- e1-14: Sulfones -- e1-15: Specialized Medications Used Against Bacteria: Bacitracin, Mupirocin, Clindamycin, Metronidazole & Tinidazole, Vancomycin, Bezlotoxumab -- e1-16: Streptogramins -- e1-17: Oxazolidinediones -- e1-18: Daptomycin -- e1-19: Telavancin, Dalbavancin, Oritavancin -- e1-20: Quinolones -- e1-21: Pentamidine & Atovaquone -- e1-22: Urinary Antiseptics -- e1-23: Antifungal Medications -- e1-24: Antiviral Chemotherapy -- Part e2: Diagnostic Testing & Medical Decision Making -- e2-01: Overview: Diagnostic Testing & Medical Decision Making -- e2-02: Benefits, Risks, & Costs of Diagnostic Tests -- e2-03: Diagnostic Test Preparation -- e2-04: Diagnostic Test Characteristics -- e2-05: Use of Tests in Diagnosis & Management -- e2-06: Likelihood Ratios & Odds-Probability Conversion in Medical Decision-Making -- Part e3: Information Technology in Patient Care -- e3-01: Overview: Information Technology in Patient Care -- e3-02: Patient Confidentiality & Information Technology -- e3-03: Clinical Uses of E-Mail -- e3-04: Electronic Health Records -- e3-05: Computerized Provider Order Entry -- e3-06: Clinical Decision Support -- e3-07: Social Media & Websites in Clinical Practice -- e3-08: Mobile Computing for Clinicians -- e3-09: Telemedicine -- Part e4: Integrative Medicine -- e4-01: Overview: Integrative Medicine -- e4-02: Herbal & Dietary Supplements -- e4-03: Botanical Medicines -- e4-04: Non-Botanical Dietary Supplements -- e4-05: Acupuncture -- e4-06: Mind-Body Medicine -- e4-07: Meditation -- e4-08: Guided Imagery -- e4-09: Biofeedback -- e4-10: Hypnosis -- e4-11: Yoga -- e4-12: Tai Chi -- Part e5: Podiatric Disorders -- e5-01: Bunion -- e5-02: Hammertoe -- e5-03: Hallux Limitus -- e5-04: Fifth Metatarsal Fracture -- e5-05: Morton Neuroma -- e5-06: Onychocryptosis (Ingrown Nail) -- e5-07: Achilles Tendonitis -- e5-08: Plantar Fasciitis -- e5-09: Plantar Plate Injuries (Predislocation Syndrome) -- e5-10: Flatfoot (Pes Planus) -- Part e6: Women's Health Issues -- e6-01: Overview: Women's Health Issues -- e6-02: Preventive Health Care in Women -- e6-03: Cardiovascular Disease Prevention in Women -- e6-04: Cancer Prevention in Women -- e6-05: Osteoporosis Prevention in Women -- e6-06: Prevention of Sexually Transmitted Infections in Women -- e6-07: Depression Screening in Women -- e6-08: Intimate Partner Violence Issues for Women -- e6-09: Human Trafficking -- e6-10: Eating Disorders in Women -- e6-11: Sexuality & Sexual Health in Women -- e6-12: Low Sexual Desire in Women -- e6-13: Chronic Pelvic Pain in Women -- e6-14: Mastalgia -- e6-15: The Palpable Breast Mass -- e6-16: Asymptomatic Ovarian Masses -- e6-17: Female Pattern Hair Loss -- Part e7: Appendix: Therapeutic Drug Monitoring & Laboratory Reference Intervals, & Pharmacogenetic Testing -- e7-01: Therapeutic Drug Monitoring -- e7-02: Reference Intervals for Commonly Used Tests -- e7-03: Selected Pharmacogenetic Tests: Clinical Relevance -- e7-04: Commonly Used Blood Specimen Collection Tubes.
요약Current Medical Diagnosis & Treatment 2021 (CMDT 2021) is the 60th edition of this single-source reference for practitioners in both hospital and ambulatory settings. The book emphasizes the practical features of clinical diagnosis and patient management in all fields of internal medicine and in specialties of interest to primary care practitioners and to subspecialists who provide general care.
이용가능한 다른형태자료Also issued in Online and PDF version.
일반주제명DiagnosisPeriodicals.
TherapeuticsPeriodicals.
바로가기URL


*주제와 무관한 내용의 서평은 삭제될 수 있습니다.

서평추가

서평추가
별점
메세지가 없습니다
  • 별5점
  • 메세지가 없습니다
  • 별4점
  • 메세지가 없습니다
  • 별3점
  • 메세지가 없습니다
  • 별2점
  • 메세지가 없습니다
  • 별1점
  • 메세지가 없습니다
  • 메세지가 없습니다

*주제와 무관한 내용의 태그는 삭제될 수 있습니다

태그추가